œŽ@–¼
  •yŠ@NŽu
  Yasushi TOMIDOKORO
   
œŠ@‘®
  ’}”g‘åŠw@‘åŠw‰@@
lŠÔ‘‡‰ÈŠwŒ¤‹†‰Èi —Õ°ˆãŠwŒn j@
޾г§ŒäˆãŠwêU@
_Œo•a‘ÔˆãŠw•ª–ì_Œo“à‰È
   
œE@–¼
  uŽt
   
œŠw@ˆÊ
  ”ŽŽmiˆãŠwjiŒQ”n‘åŠwj
   
œê–啪–ì
 

_Œo“à‰ÈŠw

   
œŒ¤‹†ƒe[ƒ}
 

ƒAƒ‹ƒcƒnƒCƒ}[•a“™‚̃Aƒ~ƒƒCƒh[ƒVƒX‚̶‰»Šw“I‰ðÍ

   
œŠ‘®Šw‰ïEŠw‰ï–ðˆõ
  E“ú–{_ŒoŠw‰ï
E“ú–{“à‰ÈŠw‰ï
E–k•Ä_Œo‰ÈŠw‰ï
E“ú–{˜V”NˆãŠw‰ï
   
œ’˜‘E˜_•¶
  Harigaya Y, et al. Type-specific evolution of amyloid plaque and angiopathy in APP SW mice. Neurosci Lett. 2006;395:37-41.
  Tomidokoro Y, et al. Familial Danish dementia: Co-existence of Danish and Alzheimer amyloid subunits (ADan and AƒÀ) in the absence of compact plaques. J Biol Chem. 2005;280:36883-36894.
  Tomidokoro Y, et al. Brain AƒÀ amyloidosis in APP SW mice induces accumulation of presenilin-1 and tau. J Pathol. 2001;194:500-506.
  Tomidokoro Y, et al. AƒÀ amyloidosis induces the initial stage of tau accumulation in APP(Sw) mice. Neurosci Lett. 2001; 299:169-172.
  Tomidokoro Y, at al. Carboxyl-terminal fragments of presenilin-1 are closely related to cytoskeletal abnormalities in Alzheimer's brains. Biochem Biophys Res Commun. 1999;256:512-518.
   
œŠwpŠÖŒWŽóÜ
   
   
œtelEfax
  tel : 029-853-3224
  fax : 029-853-3224
   
œƒ[ƒ‹ƒAƒhƒŒƒX
  tomidy01md.tsukuba.ac.jp

[—ª—ð]
1992.3 @
ŒQ”n‘åŠwˆãŠw•”ˆãŠw‰È@‘²‹Æ
1992.5
ŒQ”n‘åŠwˆãŠw•”•‘®•a‰@Œ¤Cˆã
1993.6
‘—§‚è•a‰@“à‰ÈŒ¤Cˆã
1994.6
˜V”N•aŒ¤‹†Š•‘®•a‰@_Œo“à‰ÈˆãŽt
1995.12
ŒQ”n‘åŠwˆãŠw•”•‘®•a‰@_Œo“à‰Èˆãˆõ
2000.3
ŒQ”n‘åŠw‘åŠw‰@”ŽŽm‰Û’öˆãŠwŒ¤‹†‰È“à‰ÈŒnêU@C—¹
2000.4
ŒQ”nŒ§ˆãŽt‰ï‘ò“n‰·ò•a‰@_Œo“à‰ÈˆãŽt
2000.9
ƒjƒ…[ƒˆ[ƒN‘åŠwˆãŠw•”•a—ŠwŒ¤‹†ˆõ
2006.10
Œ»E